Preclinical and Clinical Sex Differences in Antipsychotic-Induced Metabolic Disturbances: A Narrative Review of Adiposity and Glucose Metabolism

Antipsychotic (AP) medications are associated with an increased risk of developing metabolic side effects including weight gain, type 2 diabetes (T2D), dyslipidemia, and hypertension. In the majority of clinical studies, females on APs are noted to gain more weight, and are more likely to be diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellani, Laura N., Costa-Dookhan, Kenya A., McIntyre, William B., Wright, David C., Flowers, Stephanie A., Hahn, Margaret K., Ward, Kristen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760310/
https://www.ncbi.nlm.nih.gov/pubmed/31555747
http://dx.doi.org/10.20900/jpbs.20190013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760310/
https://www.ncbi.nlm.nih.gov/pubmed/31555747
http://dx.doi.org/10.20900/jpbs.20190013

Ejemplares similares